Skip to main content
  • Home
  • My Order
  • Guest
    • Order History
    • Shipping Addresses
    • Staff Accounts
  • Log in
  • Facility
    • Facility Description
    • Principal Investigator
    • NIH Staff
    • TCF Staff
    • News
  • Tetramer Science
    • Why Tetramers?
    • Publications
    • Fluorophores
  • Request Reagents
    • Request Process
    • Commercial Support
    • Unlisted
    • SARS-CoV-2/COVID-19 Reagents
    • Class I
    • Class II
    • CD1
    • CD1d Ligands
    • MR1
    • Other
  • Support
    • Website Support
    • FAQ
    • Production Protocols
    • Material Transfer Agreement
    • Technical Support
    • Review Process
    • Feedback Submission Guidelines
    • Contact Us

Papillomavirus E7 Proteins

Breadcrumb

  1. Home
X Peng, J Treml, Y Paterson. (2007) "Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy." Cancer Immunol Immunother 56. 797-806 PMID: 17102978 DOI: 10.1007/s00262-006-0240-9 | Abstract and Keywords
LM Wood, ZK Pan, V Shahabi, Y Paterson. (2010) "Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy." Cancer Immunol Immunother 59. 1049-58 PMID: 20213121 DOI: 10.1007/s00262-010-0830-4 | Abstract and Keywords
S Kanodia, DM Da Silva, T Karamanukyan, L Bogaert, YX Fu, WM Kast. (2010) "Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression." Cancer Res 70. 3955-64 PMID: 20460520 DOI: 10.1158/0008-5472.CAN-09-3773 | Abstract and Keywords
S Fresnay, X Zhang, SE Strome, DA Sewell. (2011) "Bone marrow vaccination: a novel approach to enhance antigen specific antitumor immunity." Vaccine 29. 8599-605 PMID: 21951877 DOI: 10.1016/j.vaccine.2011.09.022 | Abstract and Keywords
  • Facility
    • Facility Description
    • Principal Investigator
    • NIH Staff
    • TCF Staff
    • News
  • Tetramer Science
    • Why Tetramers?
    • Publications
    • Fluorophores
  • Request Reagents
    • Request Process
    • Commercial Support
    • Unlisted
    • SARS-CoV-2/COVID-19 Reagents
    • Class I
    • Class II
    • CD1
    • CD1d Ligands
    • MR1
    • Other
  • Support
    • Website Support
    • FAQ
    • Production Protocols
    • Material Transfer Agreement
    • Technical Support
    • Review Process
    • Feedback Submission Guidelines
    • Contact Us

Contact

NIH Tetramer Core Facility at Emory University

Emory University Vaccine Center 954 Gatewood Road Atlanta, GA 30329

Administrative Support:
tcf.manager@emory.edu

Technical Support:
tcf.scientific.support@emory.edu

Click here for more details

Copyright © 2006-2010, NIH Tetramer Core Facility at Emory University